Skip to search.
 FTSE 100 Up 0.70%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
11.16 Up 0.03(0.27%) 25 May 21:00
|After Hours: : 11.16 Up 0.00 (0.02%) 25 May 21:52
Prev Close:11.13
Open:11.20
Bid:11.00 x 300
Ask:11.50 x 200
1y Target Est:15.50
Beta:2.90616
Earnings Date:8 Aug - 12 Aug (Est.)
Day's Range:11.08 - 11.50
52wk Range:4.50 - 11.69
Volume:1,881,202
Avg Vol (3m):1,727,500
Market Cap:815.76m
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for INO at this time.

Comparison

Symbol% ChgMkt Cap
INOUp 0.27%815.76m
PFEUp 0.73%208.33b
AZNUp 1.70%75.85b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.75
Quarterly EPS Est (Jun-16) :-0.21
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback